openPR Logo
Press release

Pharmaceutical Contract Research Organization Market to Grow at 11.6% CAGR from 2023 to 2031, Driven by R&D Outsourcing and Digital Clinical Trials - According to Reed Intelligence

01-08-2026 06:04 AM CET | Health & Medicine

Press release from: Reed Intelligence

Pharmaceutical Contract Research Organization Market

Pharmaceutical Contract Research Organization Market

According to Reed Intelligence, the global Pharmaceutical Contract Research Organization (CRO) market is projected to grow at a compound annual growth rate (CAGR) of 11.6% between 2023 and 2031. Market growth is primarily driven by the increasing outsourcing of research and development (R&D) activities by pharmaceutical companies, rising demand for biopharmaceuticals, and rapid adoption of digital technologies in clinical trials.

Contract Research Organizations (CROs) support pharmaceutical, biotechnology, and medical device companies by managing complex clinical research processes, including preclinical studies, clinical trials, regulatory support, commercialization, and pharmacovigilance. The shift from paper-based systems to digital data capture, combined with the accelerated adoption of decentralized clinical trials following COVID-19, has significantly enhanced trial efficiency and data quality.

Get the Complete Report Now with Exclusive Discount: https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market/request-sample

Market Dynamics

Market Drivers

Growing R&D Outsourcing by Pharmaceutical Companies

Pharmaceutical companies are increasingly outsourcing R&D activities to CROs to reduce operational costs, improve efficiency, and gain access to specialized expertise and global clinical trial infrastructure. Outsourcing enables faster drug development timelines and access to diverse patient populations, allowing sponsors to focus on core competencies such as innovation and commercialization.

Rising Demand for Biopharmaceuticals

The increasing development of biologics, gene therapies, and personalized medicines is significantly contributing to the growth of the Pharmaceutical CRO market. These therapies require advanced technical capabilities and specialized infrastructure, driving demand for CROs with expertise in biologics development, cell and gene therapy, and biomarker research.

Market Restraints

Regulatory and Compliance Challenges

The CRO industry faces stringent regulatory requirements imposed by authorities such as the U.S. FDA and the European Medicines Agency (EMA). Ensuring compliance with evolving regulations, maintaining data integrity, and safeguarding patient safety requires continuous investment in quality systems, employee training, and compliance infrastructure, which may restrain market growth.

Market Opportunities

Emergence of Virtual and Decentralized Clinical Trials

The rise of virtual and decentralized clinical trials presents significant growth opportunities for CROs. These models leverage digital tools, remote monitoring, and telemedicine to improve patient recruitment, retention, and trial efficiency. CROs offering advanced digital trial capabilities and data management solutions are well-positioned to benefit from this trend.

Get Full Report with TOC: https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market

Market Segmentation

By Type

Active Pharmaceutical Ingredient (API)

CROs involved in API development provide services such as synthesis, purification, analytical testing, process optimization, formulation development, and stability studies to ensure product quality and safety.

Finished Dosage Formulation (FDF)

FDF services include formulation development, excipient selection, drug delivery optimization, analytical and bioanalytical testing, manufacturing, packaging, and labeling of final drug products.

By Application

Pharmaceutical & Biopharmaceutical Companies

These companies rely on CROs for preclinical research, clinical trial execution, regulatory support, data analysis, medical writing, and post-market surveillance to accelerate drug development.

Medical Device Companies

CROs support medical device firms by designing and conducting clinical studies to evaluate safety and performance, assisting with regulatory submissions, and managing post-market surveillance activities.

Academic Institutes

Academic and research institutions collaborate with CROs to access specialized expertise, advanced infrastructure, statistical analysis, regulatory guidance, and support for grant-funded research initiatives.

Get the Complete Report Now with Exclusive Discount: https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market/request-sample

Key Players in the Pharmaceutical CRO Market

IQVIA
Syneos Health
Quintiles
PPD
Parexel
ICON
PRA Health Sciences
InVentiv
INC Research Holdings
Charles River Laboratories
WuXi AppTec
Envigo
Medpace Holdings
SGS
PSI CRO
Axcent Advanced Analytics
BIO Agile Therapeutics
Firma Clinical Research
Acculab Lifesciences
Azelix
CTSERV
PEPGRA
Regional Insights

North America

North America dominates the Pharmaceutical CRO market, driven by a strong pharmaceutical and biotechnology ecosystem, advanced research infrastructure, and a favorable regulatory environment. The United States leads the region, supported by major CRO players and academic research institutions.

Europe

Europe represents a significant market, with Germany, the United Kingdom, and France leading regional growth. A robust healthcare system, strong regulatory framework, and concentration of multinational CROs support market expansion.

Asia-Pacific

Asia-Pacific is the fastest-growing region, fueled by a large patient population, increasing healthcare expenditure, and growing outsourcing of clinical trials by global pharmaceutical companies. China, India, and Japan are key contributors to regional growth.

Latin America

Latin America is witnessing steady growth due to expanding pharmaceutical industries, supportive government policies, and increasing R&D investments. Brazil remains the largest market in the region.

Middle East & Africa

The market in this region is gradually expanding, supported by improving healthcare infrastructure and rising awareness of clinical research. South Africa, Saudi Arabia, and Egypt are emerging as key markets despite regulatory and operational challenges.

Related Press Release:

https://reedintelligence.com/market-analysis/global-natural-edible-pigment-market

https://reedintelligence.com/market-analysis/global-egg-yolk-lecithin-market

https://reedintelligence.com/market-analysis/global-coffee-vending-machine-market

https://reedintelligence.com/market-analysis/global-noise-control-material-market

https://reedintelligence.com/market-analysis/global-frozen-fish-and-seafood-market

https://reedintelligence.com/market-analysis/global-sneaker-deodorant-market

https://reedintelligence.com/market-analysis/global-water-retention-agent-market

https://reedintelligence.com/market-analysis/global-pleurotus-ostreatus-market

https://reedintelligence.com/market-analysis/global-cpu-air-coolers-market

https://reedintelligence.com/market-analysis/global-anti-sensitive-mouthwash-market

https://reedintelligence.com/market-analysis/global-hv-insulators-market

https://reedintelligence.com/market-analysis/global-hvdc-systems-market

https://reedintelligence.com/market-analysis/global-zirconium-vanadium-iron-alloy-market

https://reedintelligence.com/market-analysis/global-kitchen-digital-timer-market

https://reedintelligence.com/market-analysis/global-low-voltage-capacitors-market

A global market research and management consulting firm, Reed Intelligence serves businesses, nonprofit organisations, educational institutions, and governmental organisations. Our objective is to collaborate with enterprises to achieve long-term strategic improvements and expansion targets. Our industry research papers are made to offer quantitative data together with significant industry insights. Our goal is to give our clients the information they need to achieve long-term organisational growth. We offer reports to expedite and improve the plans of our clients, whether they are looking to expand into new areas, create new solutions, or take advantage of niche growth prospects.

Contact Us:

+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Contract Research Organization Market to Grow at 11.6% CAGR from 2023 to 2031, Driven by R&D Outsourcing and Digital Clinical Trials - According to Reed Intelligence here

News-ID: 4339882 • Views:

More Releases from Reed Intelligence

Hydrogen Fuel Cells Market to Surge at 25.9% CAGR by 2031, Driven by Government Incentives and Heavy-Duty Vehicle Adoption - Reed Intelligence
Hydrogen Fuel Cells Market to Surge at 25.9% CAGR by 2031, Driven by Government …
According to a new report by Reed Intelligence, the global Hydrogen Fuel Cells Market is projected to experience a robust growth trajectory, with an expected compound annual growth rate (CAGR) of 25.9% from 2023 to 2031. The market's rapid expansion is largely driven by government incentives promoting clean energy adoption and increasing utilization in heavy-duty vehicles. The report offers in-depth insights into market dynamics, regional trends, commercial developments, and competitive strategies.
Carbon Capture and Storage Market Poised for Robust Growth with 6% CAGR by 2031, Straits Research
Carbon Capture and Storage Market Poised for Robust Growth with 6% CAGR by 2031, …
According to a comprehensive market research report by Reed Intelligence, the global Carbon Capture and Storage (CCS) Market is projected to witness significant growth over the forecast period 2023-2031, registering an approximate compound annual growth rate (CAGR) of 6%. This growth is primarily driven by increasing climate change regulations, rising awareness of carbon footprints, and continuous advancements in CCS technology. The report provides an in-depth analysis of market dynamics, opportunities, trends,
Underground Power Cables Market to Register 14.6% CAGR Through 2031, Says Reed Intelligence
Underground Power Cables Market to Register 14.6% CAGR Through 2031, Says Reed I …
According to Reed Intelligence, the Global Underground Power Cables Market is projected to grow at a compound annual growth rate (CAGR) of approximately 14.6% during the forecast period. The market expansion is driven by rapid urbanization, large-scale infrastructure development, grid modernization initiatives, and stringent government regulations focused on safety and environmental sustainability. Underground power cables are electrical conductors installed beneath the earth's surface to transmit and distribute electricity. Unlike overhead transmission
Integrated Operating Room System Market to Expand at 11.5% CAGR Through 2031 - Reed Intelligence
Integrated Operating Room System Market to Expand at 11.5% CAGR Through 2031 - R …
According to Reed Intelligence, the Global Integrated Operating Room (IOR) System Market is projected to grow at a compound annual growth rate (CAGR) of approximately 11.5% during the forecast period from 2023 to 2031. This strong growth outlook is supported by the rising adoption of minimally invasive surgeries, increasing digitalization in healthcare infrastructure, and growing demand for advanced surgical environments. An Integrated Operating Room (IOR) is a technologically advanced surgical suite

All 5 Releases


More Releases for CRO

Contract Research Organization (CRO) Research: China CRO market size is projecte …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Contract Research Organization (CRO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028. The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028. The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630 This latest report
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer. Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues